Investment
Features
FeesSafety
Academy
More
Pluang+

Sirios Resources reports strong gold assay results from initial drilling at Cheechoo project in Quebec.

Market News
20 Aug 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Sirios Resources announced assay results from the first 5 drill holes totaling 1,753 meters at its Cheechoo gold project in Quebec. Highlights include high-grade gold intervals such as 2.40 g/t over 48.5 meters and visible gold in 8 holes, indicating potential resource expansion beyond the 2025 estimate. With 33 holes completed and 4 rigs active, the company expects to finish Phase 1 drilling by September and update its resource estimate soon. These results support the potential for significant growth of the Cheechoo deposit.

More News

Nvidia's strong earnings outlook fuels analyst optimism and potential stock valuation upside.

Nvidia's strong earnings outlook fuels analyst optimism and potential stock valuation upside.

Nvidia, a leading semiconductor and AI company, is expected to report strong Q2 fiscal 2027 earnings on August 26, with analysts anticipating revenue around $91.9 billion and adjusted earnings of $2.08 per share. RBC Capital maintains an "Outperform"...

Analyst Insights
Bullish
53 minutes ago
Deere & Company beats Q3 earnings and revenue estimates, driven by strong construction equipment sales.

Deere & Company beats Q3 earnings and revenue estimates, driven by strong construction equipment sales.

Deere & Company reported third-quarter earnings per share of $5.10, surpassing analyst expectations of $4.71, and revenue of $12.61 billion, exceeding estimates of $10.81 billion. The growth was mainly driven by strong performance in the construction...

Company Fundamentals
Bullish
58 minutes ago
AbbVie price target raised to $303 as institutional investors boost holdings, signaling strong confidence.

AbbVie price target raised to $303 as institutional investors boost holdings, signaling strong confidence.

Piper Sandler raised AbbVie's price target to $303, indicating a potential 13.92% upside from its current price of $265.97. This reflects positive expectations for the biopharmaceutical company's future performance. Institutional investors like J. M....

Analyst Insights
Bullish
1 hour ago
BTIG raises Glaukos price target to $202 on strong sales growth and raised 2026 revenue guidance.

BTIG raises Glaukos price target to $202 on strong sales growth and raised 2026 revenue guidance.

BTIG reaffirmed its 'Buy' rating for Glaukos and increased the price target to $202, citing strong sales growth. U.S. glaucoma sales rose 64% to $118.5 million, driven by the iDose TR product, while Corneal Health revenues grew 48% to $30.4 million, ...

Analyst Insights
Bullish
1 hour ago
Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...

Market News
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App